These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21352854)

  • 21. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
    Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
    J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of B cell responses by Toll-like receptors.
    Booth J; Wilson H; Jimbo S; Mutwiri G
    Cell Tissue Res; 2011 Jan; 343(1):131-40. PubMed ID: 20824286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T cell activation by TLRs: a role for TLRs in the adaptive immune response.
    MacLeod H; Wetzler LM
    Sci STKE; 2007 Sep; 2007(402):pe48. PubMed ID: 17785715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
    Ruprecht CR; Lanzavecchia A
    Eur J Immunol; 2006 Apr; 36(4):810-6. PubMed ID: 16541472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptors: paving the path to T cell-driven autoimmunity?
    Marsland BJ; Kopf M
    Curr Opin Immunol; 2007 Dec; 19(6):611-4. PubMed ID: 17888644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
    Ahonen CL; Doxsee CL; McGurran SM; Riter TR; Wade WF; Barth RJ; Vasilakos JP; Noelle RJ; Kedl RM
    J Exp Med; 2004 Mar; 199(6):775-84. PubMed ID: 15007094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system.
    Netea MG; van der Graaf C; Van der Meer JW; Kullberg BJ
    J Leukoc Biol; 2004 May; 75(5):749-55. PubMed ID: 15075354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors' two-edged sword: when immunity meets apoptosis.
    Salaun B; Romero P; Lebecque S
    Eur J Immunol; 2007 Dec; 37(12):3311-8. PubMed ID: 18034428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
    Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
    Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells and Toll-like receptors in tumor immunity.
    Wang RF; Peng G; Wang HY
    Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR signaling by tumor and immune cells: a double-edged sword.
    Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
    Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors in human papillomavirus infection.
    Zhou Q; Zhu K; Cheng H
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma.
    Deng S; Zhu S; Qiao Y; Liu YJ; Chen W; Zhao G; Chen J
    Protein Cell; 2014 Dec; 5(12):899-911. PubMed ID: 25411122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses.
    Shinde P; Bharat V; Rodriguez-Oquendo A; Zhou B; Vella AT
    Expert Opin Biol Ther; 2018 Oct; 18(10):1073-1083. PubMed ID: 30169979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy.
    Noh JY; Yoon SR; Kim TD; Choi I; Jung H
    J Immunol Res; 2020; 2020():2045860. PubMed ID: 32377528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia.
    Spaner DE; Masellis A
    Leukemia; 2007 Jan; 21(1):53-60. PubMed ID: 17066089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor signaling in parasitic infections.
    Ashour DS
    Expert Rev Clin Immunol; 2015 Jun; 11(6):771-80. PubMed ID: 25896399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.